151 related articles for article (PubMed ID: 7504344)
1. Depletion of the helper/inducer (memory) T cell subset using a bispecific antibody-toxin conjugate directed against CD4 and CD29.
Duke-Cohan JS; Morimoto C; Schlossman SF
Transplantation; 1993 Nov; 56(5):1188-96. PubMed ID: 7504344
[TBL] [Abstract][Full Text] [Related]
2. Targeting of an activated T-cell subset using a bispecific antibody-toxin conjugate directed against CD4 and CD26.
Duke-Cohan JS; Morimoto C; Schlossman SF
Blood; 1993 Oct; 82(7):2224-34. PubMed ID: 8104537
[TBL] [Abstract][Full Text] [Related]
3. Bispecific antibody-directed antitumor activity of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus interleukin 2.
Nishimura T; Nakamura Y; Takeuchi Y; Gao XH; Tokuda Y; Okumura K; Habu S
Jpn J Cancer Res; 1991 Nov; 82(11):1207-10. PubMed ID: 1836455
[TBL] [Abstract][Full Text] [Related]
4. Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.
Wawrzynczak EJ; Watson GJ; Cumber AJ; Henry RV; Parnell GD; Rieber EP; Thorpe PE
Cancer Immunol Immunother; 1991; 32(5):289-95. PubMed ID: 1998970
[TBL] [Abstract][Full Text] [Related]
5. Concomitant augmentation of CD4+ CD29+ helper inducer and diminution of CD4+ CD45RA+ suppressor inducer subset in patients infected with human T cell lymphotropic virus types I or II.
Lal RB; Rudolph DL; Schmid DS; Lairmore MD
Clin Exp Immunol; 1992 Feb; 87(2):293-7. PubMed ID: 1370929
[TBL] [Abstract][Full Text] [Related]
6. Differential responses of CD4+CD45RA+ and CD4+CD29+ subsets to activated CD8+ cells: enhanced stimulation of the CD4+CD45RA+ subset by cells from patients with multiple sclerosis.
Freedman MS; Blain M; Antel JP
Cell Immunol; 1991 Apr; 133(2):306-16. PubMed ID: 1707762
[TBL] [Abstract][Full Text] [Related]
7. A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cells.
Chamow SM; Zhang D; Tan XY; Mhatre SM; Marsters SA; Peers DH; Byrn RA; Ashkenazi A; Junghans RP
J Hematother; 1995 Oct; 4(5):439-46. PubMed ID: 8581382
[TBL] [Abstract][Full Text] [Related]
8. Bispecific anti-CD22/anti-CD3-ricin A chain immunotoxin is cytotoxic to Daudi lymphoma cells but not T cells in vitro and shows both A-chain-mediated and LAK-T-mediated killing.
Shen GL; Li JL; Vitetta ES
J Immunol; 1994 Mar; 152(5):2368-76. PubMed ID: 8133047
[TBL] [Abstract][Full Text] [Related]
9. Role of T-cell subsets in the bispecific antibody (anti-idiotype x anti-CD3) treatment of the BCL1 lymphoma.
Demanet C; Brissinck J; Leo O; Moser M; Thielemans K
Cancer Res; 1994 Jun; 54(11):2973-8. PubMed ID: 8187084
[TBL] [Abstract][Full Text] [Related]
10. T lymphocyte subset abnormalities in peripheral blood from patients with the Guillain-Barré syndrome.
Dahle C; Vrethem M; Ernerudh J
J Neuroimmunol; 1994 Sep; 53(2):219-25. PubMed ID: 7520920
[TBL] [Abstract][Full Text] [Related]
11. Imbalance of CD4+CD29+ and CD4+CD45RA+ T-helper cell subsets in peripheral blood of patients with severe atopic dermatitis.
Jung K; Bittrich A; Klimmek V; Schubert H
Arch Dermatol Res; 1993; 285(3):135-9. PubMed ID: 7684891
[TBL] [Abstract][Full Text] [Related]
12. Anti-CD6-blocked ricin: an anti-pan T-cell immunotoxin.
Collinson AR; Lambert JM; Liu Y; O'Dea C; Shah SA; Rasmussen RA; Goldmacher VS
Int J Immunopharmacol; 1994 Jan; 16(1):37-49. PubMed ID: 8150554
[TBL] [Abstract][Full Text] [Related]
13. Insights into the molecular basis of a bispecific antibody's target selectivity.
Mazor Y; Hansen A; Yang C; Chowdhury PS; Wang J; Stephens G; Wu H; Dall'Acqua WF
MAbs; 2015; 7(3):461-9. PubMed ID: 25730144
[TBL] [Abstract][Full Text] [Related]
14. Imbalance of CD4+ lymphocyte subsets in patients with mixed connective tissue disease.
Becker H; Langrock A; Federlin K
Clin Exp Immunol; 1992 Apr; 88(1):91-5. PubMed ID: 1373354
[TBL] [Abstract][Full Text] [Related]
15. Requirement of monocytes and T-helper cells during development of tumor cell cytotoxicity in targeted T cells.
Smans KA; Hoylaerts MF; De Broe ME
Cancer Immunol Immunother; 1994 Jan; 38(1):43-52. PubMed ID: 8299118
[TBL] [Abstract][Full Text] [Related]
16. Modeling bispecific monoclonal antibody interaction with two cell membrane targets indicates the importance of surface diffusion.
Sengers BG; McGinty S; Nouri FZ; Argungu M; Hawkins E; Hadji A; Weber A; Taylor A; Sepp A
MAbs; 2016 Jul; 8(5):905-15. PubMed ID: 27097222
[TBL] [Abstract][Full Text] [Related]
17. Imbalance of CD4+CD45R+ and CD4+CD29+ T helper cell subsets in patients with atopic diseases.
Schauer U; Jung T; Heymanns J; Rieger CH
Clin Exp Immunol; 1991 Jan; 83(1):25-9. PubMed ID: 1703056
[TBL] [Abstract][Full Text] [Related]
18. Abnormalities of T lymphocyte subsets in Behçet's disease demonstrated with anti-CD45RA and anti-CD29 monoclonal antibodies.
Kahan A; Hamzaoui K; Ayed K
J Rheumatol; 1992 May; 19(5):742-6. PubMed ID: 1377274
[TBL] [Abstract][Full Text] [Related]
19. CD21+ (B2 antigen+) cell decrement and CD4+CD29+ (helper-inducer) cell increment suggest an activation of cell immune reactivity in multiple sclerosis.
Gambi D; Porrini AM; Giampietro A; Macor S
J Neuroimmunol; 1991 Aug; 33(2):97-102. PubMed ID: 1712366
[TBL] [Abstract][Full Text] [Related]
20. Effects of job strain on helper-inducer (CD4+CD29+) and suppressor-inducer (CD4+CD45RA+) T cells in Japanese blue-collar workers.
Kawakami N; Tanigawa T; Araki S; Nakata A; Sakurai S; Yokoyama K; Morita Y
Psychother Psychosom; 1997; 66(4):192-8. PubMed ID: 9259042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
